1. Home
  2. CLPS vs NXL Comparison

CLPS vs NXL Comparison

Compare CLPS & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLPS
    SELLHOLDBUYas of 2 days ago
  • NXL
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • CLPS 2005
  • NXL 2010
  • Country
  • CLPS Hong Kong
  • NXL United States
  • Employees
  • CLPS N/A
  • NXL N/A
  • Industry
  • CLPS Computer Software: Prepackaged Software
  • NXL Medical Specialities
  • Sector
  • CLPS Technology
  • NXL Health Care
  • Exchange
  • CLPS Nasdaq
  • NXL Nasdaq
  • Market Cap
  • CLPS 32.7M
  • NXL 31.1M
  • IPO Year
  • CLPS 2018
  • NXL 2022
  • Fundamental
  • Price
  • CLPS $1.19
  • NXL $1.94
  • Analyst Decision
  • CLPS
  • NXL Strong Buy
  • Analyst Count
  • CLPS 0
  • NXL 1
  • Target Price
  • CLPS N/A
  • NXL $5.00
  • AVG Volume (30 Days)
  • CLPS 10.0K
  • NXL 124.0K
  • Earning Date
  • CLPS 03-05-2025
  • NXL 03-14-2025
  • Dividend Yield
  • CLPS 10.92%
  • NXL N/A
  • EPS Growth
  • CLPS N/A
  • NXL N/A
  • EPS
  • CLPS N/A
  • NXL N/A
  • Revenue
  • CLPS $153,816,045.00
  • NXL $168,721.00
  • Revenue This Year
  • CLPS N/A
  • NXL $175.37
  • Revenue Next Year
  • CLPS N/A
  • NXL $334.78
  • P/E Ratio
  • CLPS N/A
  • NXL N/A
  • Revenue Growth
  • CLPS 5.81
  • NXL 52.35
  • 52 Week Low
  • CLPS $0.68
  • NXL $0.53
  • 52 Week High
  • CLPS $1.70
  • NXL $4.49
  • Technical
  • Relative Strength Index (RSI)
  • CLPS 48.65
  • NXL 37.77
  • Support Level
  • CLPS $1.16
  • NXL $2.16
  • Resistance Level
  • CLPS $1.21
  • NXL $2.57
  • Average True Range (ATR)
  • CLPS 0.03
  • NXL 0.22
  • MACD
  • CLPS 0.00
  • NXL -0.00
  • Stochastic Oscillator
  • CLPS 50.00
  • NXL 9.52

Stock Price Comparison Chart: CLPS vs NXL

CLPS
NXL
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250.00.51.01.52.02.53.03.54.04.5CLPS VS NXL

About CLPS CLPS Incorporation

CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use